BiotechTube
Home/Psyence Biomedical/Dr. Michael Spigelman
DM

Dr. Michael Spigelman

Executive Chairman (historical)

Psyence Biomedical

Therapeutic Areas

Mental HealthOncology Supportive Care

Psyence Biomedical Pipeline

DrugIndicationPhase
Natural Psilocybin (PEX010)Adjustment Disorder due to a recent diagnosis of incurable cancerPhase IIb

Leadership Team at Psyence Biomedical

DN
Dr. Neil Maresky
Chief Executive Officer
SG
Stephen G. L. Smith
Director
View full Psyence Biomedical profile